Background And Purpose: Manual treatment planning for cervical brachytherapy is a challenging task; therefore, we investigated a method for inverse treatment planning using pseudo-structures to control the dwell distribution. Our hypothesis was that this method could produce treatment plans with a pear-shaped dose distribution and a high central dose, that comply with clinical constraints.
Materials And Methods: Data from 16 previously treated patients were used to compare three treatment planning methods: i) manual, ii) straightforward inverse, and iii) inverse with pseudo-structures. The treatment plans were compared using dose-volume histogram parameters and by analysing the dwell times, and the distribution of total reference air-kerma (TRAK) in the different parts of the applicator. Methods were evaluated in one treatment planning system and verified in a second treatment planning system.
Results: The median dose to 90 % of the clinical tumor volume was 7.6 Gy, 7.8 Gy and 8.1 Gy for manual, pseudo-structure and straightforward methods respectively. Distribution of TRAK for the different parts of the applicator for the three methods (manual, pseudo-structures, and straightforward), with combined intracavitary and interstitial treatments, were for vaginal part 39 %, 33 % and 15 %, for intra-uterine part 47 %, 50 % and 47 % and for interstitial part 13 %, 17 % and 38 % respectively. The results were similar in the second treatment planning system.
Conclusion: The developed pseudo-structures worked as intended in shaping the dwell time distribution and in meeting the clinical constraints for both investigated treatment planning systems.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11605463 | PMC |
http://dx.doi.org/10.1016/j.phro.2024.100672 | DOI Listing |
Health Promot Pract
January 2025
The University of Utah College of Nursing, Salt Lake City, UT, USA.
Cervical cancer is the leading cause of cancer-related death among Latin American women, including Guatemalans. This is troubling, given we have a vaccine, screening tool, and treatment for this preventable disease. Human papillomavirus (HPV) causes most cervical cancer.
View Article and Find Full Text PDFAfr J Prim Health Care Fam Med
December 2024
Department of Anaesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver.
In older adults with type 2 diabetes (T2DM), tight glycaemic control (HbA1c 7%) can result in more harm than benefit, especially when using insulin or sulfonylureas. Older adults are at higher risk for adverse drug events, especially hypoglycaemia, which may cause falls, confusion and hospitalisations. This Therapeutic Letter evaluates the risks of tight glycaemic control in older adults with T2DM, focusing on deprescribing diabetes medications in those over 65, especially those with multimorbidity and polypharmacy.
View Article and Find Full Text PDFFront Neurol
January 2025
Department of Neurology, The Third People's Hospital of Yibin, Yibin, China.
Objective: To evaluate the clinical utility of improved machine learning models in predicting poor prognosis following endovascular intervention for intracranial aneurysms and to develop a corresponding visualization system.
Methods: A total of 303 patients with intracranial aneurysms treated with endovascular intervention at four hospitals (FuShun County Zigong City People's Hospital, Nanchong Central Hospital, The Third People's Hospital of Yibin, The Sixth People's Hospital of Yibin) from January 2022 to September 2023 were selected. These patients were divided into a good prognosis group ( = 207) and a poor prognosis group ( = 96).
Front Med (Lausanne)
January 2025
Department of Hand and Microsurgery, Peking University Shenzhen Hospital, Shenzhen, China.
Necrotising soft tissue infections (NSTIs) are one of the most challenging and severe forms of infections. The prognosis requires accurate and aggressive diagnosis and management. In this case, we present an unexplained case of concurrence of TE events following BKA for the surgical management of NSTI.
View Article and Find Full Text PDFActa Endocrinol (Buchar)
January 2025
Ankara University School of Medicine, Department of Pediatric Endocrinology.
Unlabelled: Denosumab,a monoclonal IgG2 antibody directed against RANK-L,is used as a neoadjuvant therapy for inoperable or metastatic giant cell tumor of bone. Many side effects like as hypocalcemia during treatment and rarely severe hypercalcemia especially in children after discontinuation of denosumab occurred. The unpredictable onset and recurrent episodes of severe hypercalcemia increase the duration of hospitalization and the risk of complications.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!